课题基金 / 基金详情

Significance and Function of HGAL in Lymphoma

Significance and Function of HGAL in Lymphoma
HGAL 在淋巴瘤中的意义和功能
批准号:
8463466
负责人:
IZIDORE S LOSSOS
金额:
$22.86万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2014-05-31
关键词:
ActinsActomyosinAffectAntigensAtypical lymphocyteB-Cell Lymphoma 6 ProteinB-LymphocytesBehaviorBindingBiologicalBiological ProcessBiologyC-terminalCell CommunicationCell Differentiation processCell Migration Inhibition functionCell physiologyCellsCharacteristicsClinicalCloningComplexCytoskeletonDataDevelopmentDiagnosisDiseaseEnvironmentExpressed Sequence TagsFamilyFilopodiaFundingGene Expression ProfilingGenesGoalsGrantHistocompatibility Antigens Class IIHodgkin DiseaseHumanImmune responseInterleukin-6KnowledgeLaboratoriesLeadLymphocyteLymphocyte BiologyLymphomaLymphomagenesisMalignant - descriptorMediatingMediator of activation proteinMolecularMolecular TargetMotorMyosin ATPaseMyosin Regulatory Light ChainsMyosin Type IIN-terminalNeoplasm MetastasisNon-Hodgkin&aposs LymphomaOutcomePathogenesisPathologic ProcessesPatientsPhosphorylationPhysiologicalPhysiological ProcessesPlayPredispositionProcessPrognostic MarkerProteinsReactionReagentRegulationResearchRoleSiteStructureStructure of germinal center of lymph nodeTestingTimeTissuesTransgenic MiceTumor ImmunityTyrosineWound Healingabstractingangiogenesisbasecancer therapycell mediated immune responsecell motilitygene cloningimprovedin vivolarge cell Diffuse non-Hodgkin&aposs lymphomalymphoid neoplasmmalignant lymphocytemembermigrationmouse modelmyristoylationneoplastic cellnovelnovel strategiesnovel therapeutic interventionnovel therapeuticsoutcome forecastoverexpressionpreventresponserho GTP-Binding ProteinsrhoA GTP-Binding Proteintooltreatment strategytumor

项目摘要

项目成果

IZIDORE S LOSSOS的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
Project Summary/Abstract This project is based on our findings that high expression of Human Germinal center Associated Lymphoma (HGAL) - a new gene that we cloned and characterized - is an independent predictor of prolonged survival of diffuse large B cell lymphoma (DLBCL) and Hodgkin's disease (HD) patients. Recently, we demonstrated that HGAL mediates IL-6-induced inhibition of germinal center (GC) B-cell migration. We demonstrated that IL-6 induces Lyn-mediated phosphorylation of the HGAL C-terminal tyrosine and causes HGAL relocalization to podosome-like structures and spike-like filopodia. We showed interactions between endogenous HGAL and myosin II and delineated HGAL domains responsible for the interaction. We provided evidence that HGAL phosphorylation results in increased interaction with the myosin II and demonstrated that knockdown of endogenous HGAL ameliorates the inhibitory effects of the IL-6 on cell migration. Taken together, these results identified HGAL as a physiological mediator of IL-6 effects on lymphocyte migration and suggest that HGAL expression in GC-derived lymphomas may limit tumor dissemination and predispose to better clinical outcome. However, despite the marked progress in identifying HGAL role in cellular processes, the precise mechanisms of HGAL-mediated inhibition of cell migration and consequent predisposition to better clinical outcome of tumors expressing HGAL are presently unknown. Our preliminary data demonstrates that HGAL may affect cell motility by interacting with myosin II and/or by increasing RoA activity. However, these effects need to be further investigated. In this project we will: 1) Determine effects of HGAL on myosin II function; 2) Determine effects of HGAL on a member of the small Rho GTPase family - RhoA protein and its effectors; 3) Determine the role of HGAL myristoylation and palmytoylation on its inhibitory effects on cell motility; and 4) Determine the effects of HGAL expression in transgenic mice model on lymphocyte differentiation, maturation, motility and lymphomagenesis. These studies will expand our knowledge on biology of the GC lymphocytes, with specific emphasis on lymphocyte motility and migration. Furthermore, these studies will reveal potentially new mechanisms regulating dissemination and progression of lymphoid tumors. These mechanistic studies may provide novel approaches for new therapeutic.
期刊论文(66)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/ajh.23996
发表时间: 2015-06
期刊: AMERICAN JOURNAL OF HEMATOLOGY
影响因子: 12.8
作者: [Hosein, Peter J., Sandoval-Sus, Jose D., Goodman, Deborah, Arteaga, Alexandra Gomez, Reis, Isildinha, Hoffman, James, Stefanovic, Alexandra, Rosenblatt, Joseph D., Lossos, Izidore S.]
通讯作者: Lossos, Izidore S.
Biased immunoglobulin light chain use in the Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.
偏向免疫球蛋白轻链在鹦鹉热衣原体阴性眼附件边缘区淋巴瘤中的应用。
DOI: 10.1002/ajh.23416
发表时间: 2013
期刊: American journal of hematology
影响因子: 12.8
作者: [Zhu,Daxing, Lossos,Chen, Chapman-Fredricks,JenniferR, Lossos,IzidoreS]
通讯作者: Lossos,IzidoreS
Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.
鹦鹉热衣原体阴性眼附件边缘区淋巴瘤的分子和基因组畸变。
DOI: 10.1002/ajh.23490
发表时间: 2013
期刊: American journal of hematology
影响因子: 12.8
作者: [Zhu,Daxing, Ikpatt,OffiongF, Dubovy,SanderR, Lossos,Chen, Natkunam,Yasodha, Chapman-Fredricks,JenniferR, Fan,Yao-Shan, Lossos,IzidoreS]
通讯作者: Lossos,IzidoreS
DOI: 10.18632/aging.100244
发表时间: 2010-12
期刊: Aging
影响因子: --
作者: [Vicente-Dueñas C, Abollo-Jiménez F, Ruiz-Roca L, Alonso-Escudero E, Jiménez R, Cenador MB, Criado FJ, Cobaleda C, Sánchez-García I]
通讯作者: Sánchez-García I
共 23 条
    Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
    Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
    Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
    Prognostic Models in Diffuse Large B-Cell Lymphoma
    国内基金
    海外基金
    由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
    • 批准号:
      82360313
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32万元
    • 批准年份:
      2023
    • 负责人:
      滕藤
    • 依托单位: